NEW DELHI: We expect that the choices will be done swiftly but those who are getting Covaxin do have obligations of travel, etc., for which WHO’s consent is vital says member of Niti Aayog, Dr. VK Paul.
Dr. VK Paul, National Expert Committee chairman for Vaccine Administration told reporters that the WHO’s acceptance for emergency utilization of Covaxin, which will announce it secure for the use in other countries and ultimately allow people who receive the vaccine to travel overseas without prescribed quarantine, could come before the end of September.
Since July, technical experts have been reviewing Bharat Biotech’s dossier for consideration.
ANI news agency cited him as saying that we are aware of positive advances, such as data exchange and data appraisal under numerous evaluations, and are aware that we are nearing a decision point. We anticipate a favorable decision will be made by the end of the month.
Bharat Biotech had submitted an application for pre-qualification on July 9, according to Minister of State for Health Bharati Pravin Pawar.
The Serum Institute of India’s Covishield has been pre-qualified by the World Health Organization.
She stated that based on the time it took for the other vaccines of COVID-19 to be approved; the WHO process is expected to take two to three months from date of application.
In June, India and the European Union had a spat over the EU’s refusing to take Indian-made vaccinations as “vaccination passports”.
If the EU’s stance does not change, India has stated that it will adopt a reciprocal policy concerning quarantine exemption for arriving travelers.
Following that, eight countries In the European Union agreed that they will accept the Covishield, which is made in India.